Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03275402 |
Title | 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Y-mAbs Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | child |
Covered Countries | USA | ESP | DNK |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Childrens Hospital Los Angeles | Los Angeles | California | 90027 | United States | Details | |
Riley Hospital for Children | Indianapolis | Indiana | 46202 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Nationwide Children's Hospital | Columbus | Ohio | 43205 | United States | Details | |
M.D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Rigshospitalet | København | 2100 | Denmark | Details | ||
Department of Pediatric Oncology Fukushima Medical University Hospita | Fukushima City | 960-1295 | Japan | Details | ||
Hospital Sant Joan de Déu | Barcelona | 08010 | Spain | Details |